Skip to content

Pyruvate Kinase Deficiency Global Longitudinal Registry

Pyruvate Kinase Deficiency

This study is an observational (ie, noninterventional), longitudinal, multicenter, global registry for patients with pyruvate kinase (PK) deficiency, a rare nonspherocytic hemolytic anemia.

This Registry will be open for enrollment for 7 years and all enrolled participants will be followed prospectively for a minimum of 2 years, and up to 9 years.

Data will be collected from participating Registry Physicians, participants, and, where appropriate, parents/guardians who have provided informed consent or assent (where relevant) and authorization pursuant to applicable laws and regulations.

Data should include demographic, clinical, and treatment data; and other data of relevance to the management of patients with PK deficiency. Annual chart review and data entry are expected in order to enhance longitudinal understanding of PK deficiency; however, no specific protocol schedule of assessment is required by this Registry protocol.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* Participants of all ages with a confirmed diagnosis of PK deficiency via genetic testing are eligible to enroll;
* Participants will be considered for enrollment on the basis of clinical features consistent with PK deficiency together with the presence of 2 or more PKLR gene mutations. For novel or indeterminate PKLR gene mutations, participants will be deemed eligible if, in the opinion of the investigator, the reported PKLR gene mutations are sufficient to support a diagnosis of PK deficiency;
* The participant or the parent/guardian of the participant must be willing and able to give written informed consent and/or assent. E-consent or remote consent may be utilized where permissible as applicable if country regulations and site policies allow.

Lieu de l'étude

St. Justine Hospital
St. Justine Hospital
Montreal, Quebec
Canada

Contactez l'équipe d'étude

Toronto General Hospital
Toronto General Hospital
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Saint Josephs Healthcare System
Saint Josephs Healthcare System
Hamilton, Ontario
Canada

Contactez l'équipe d'étude

Étude parrainée par
Agios Pharmaceuticals, Inc.
Participants recherchés
Plus d'informations
ID de l'étude: NCT03481738